M. R. Joysoual, S. Ara, S. Razzaque, and M. Islam, “Safety of Empagliflozin as Add-on Therapy in Patients with Uncontrolled Type 2 Diabetes Mellitus”, Khwaja Yunus Ali Medical College Journal, vol. 16, no. 3, pp. 119–122, Jun. 2026.